Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
GlobeNewswire
Ultragenyx Announces Positive Longer-term Results from First Three Cohorts of Phase 1/2 Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
May 13, 2020 -
PR Newswire
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 13, 2020 -
GlobeNewswire
SPEAR T-cells Derived from Stem-Cells Kill Cancer Targets – Adaptimmune Presents Advances from its Allogeneic Platform at ASGCT Annual Meeting
May 12, 2020 -
GlobeNewswire
Arvelle Therapeutics: SK Life Science, Inc. Announces US Availability of XCOPRI® (cenobamate tablets) for the Treatment of Partial (Focal) Onset Seizures in Adults with Epilepsy
May 12, 2020 -
FierceBiotech
Next-gen biotech Caribou Biosciences nabs Array (now Pfizer) cancer R&D exec as clinical lead
May 12, 2020 -
GlobeNewswire
Tempest Therapeutics Announces First Patient Dosed in TPST-1495 Clinical Study: Dual EP2/4 Antagonist Targeting Solid Tumors
May 7, 2020 -
PR Newswire
FARAPULSE’s Pioneering Clinical Results Link Compelling Long-term Outcomes to Established Safety and Lesion Durability Data
May 7, 2020 -
TechCrunch
Owkin raises $25 million as it builds a secure network for healthcare analysis and research
May 7, 2020 -
PR Newswire
Caribou Biosciences and MaxCyte Enter into Clinical and Commercial License Agreement
May 7, 2020 -
PR Newswire
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
May 6, 2020 -
GlobeNewswire
GeneTx and Ultragenyx Announce GTX-102 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome
May 4, 2020 -
Business Wire
SonderMind hires Douglas Newton, MD, MPH as Chief Medical Officer
May 4, 2020 -
EurekAlert
Frost & Sullivan recognizes Insilico as innovation leader in drug discovery
April 30, 2020 -
PR Newswire
Pharmaceutical Manufacturers and Wholesalers Continue to Choose TraceLink As Industry Readies for DSCSA Saleable Returns Verification Requirement
April 29, 2020 -
GlobeNewswire
Apellis Reports Analysis from Phase 1b Geographic Atrophy Study
April 28, 2020 -
Business Wire
Avalyn Pharma Secures $35.5 Million Series B Financing, Broadens Development Portfolio
April 27, 2020 -
PR Newswire
Innovent Announces First Patient Dosed in a Pivotal Trial of Parsaclisib in Patients with Indolent Lymphoma in China
April 27, 2020 -
PR Newswire
Novaerus Defend 1050 Proven to Reduce Coronavirus Surrogate by 99.99%
April 27, 2020 -
Business Wire
Xilio Therapeutics Appoints Martin H. Huber, M.D. as Chief Medical Officer
April 27, 2020 -
PR Newswire
Applied BioMath, LLC Announces Collaboration with Xilio Therapeutics
April 27, 2020 -
Business Wire
Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi-Year Collaboration to Discover and Develop Novel AAV Capsids for Genetic Therapies
April 27, 2020 -
GlobeNewswire
Orchard Therapeutics Announces First Patient Dosed with OTL-201 Gene Therapy in Proof-of-Concept Clinical Trial for Sanfilippo Syndrome (MPS-IIIA)
April 27, 2020 -
PR Newswire
Insilico Medicine enters into a collaboration research with Astellas Pharma Inc. to apply novel generative artificial intelligence system for a conventionally challenging target family
April 27, 2020 -
GlobeNewswire
Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)
April 26, 2020 -
PR Newswire
Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
April 23, 2020 -
GlobeNewswire
Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388
April 23, 2020 -
PR Newswire
Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
April 20, 2020 -
PR Newswire
TraceLink Announces $1 Million Charitable Funding for COVID-19 Relief, Issues Call for Grant Proposals
April 16, 2020 -
GlobeNewswire
Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources
April 15, 2020 -
FierceBiotech
Boehringer Ingelheim taps Insilico Medicine for AI drug target collaboration
April 14, 2020 -
PR Newswire
Centivo Launches New Health Plan Solution
April 9, 2020 -
GlobeNewswire
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR20A for Relapsed/Refractory NHL, CLL, and SLL
April 7, 2020 -
Business Wire
Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST™ Technology for its CAR-T pipeline
April 7, 2020 -
Business Wire
SonderMind Raises $27 Million to Expand its Accessible Behavioral Health Platform
April 6, 2020 -
FierceBiotech
Compass Therapeutics’ immuno-oncology prospect clears solid tumors in mice
April 3, 2020 -
PR Newswire
Blueprint Medicines Announces the Achievement of Key Portfolio Milestones
April 1, 2020 -
GlobeNewswire
Orchard Therapeutics Outlines Business Impact of COVID-19
March 31, 2020 -
GlobeNewswire
REGENXBIO and Ultragenyx Announce New License Agreement for Use of NAV® Technology Platform for the Treatment of Rare Metabolic Disorder
March 31, 2020 -
GlobeNewswire
Affinia Therapeutics Raises $60M in Series A Financing to Advance Rational Design AAV Platform and Transformative Gene Therapies
March 31, 2020 -
GlobeNewswire
Arvelle Announces European Medicines Agency Acceptance of the Marketing Authorization Application (MAA) for Cenobamate
March 30, 2020 -
GlobeNewswire
Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China
March 25, 2020 -
PR Newswire
AI-Derived COVID-19 Experimental Data and Reagent Insights Now Available From BenchSci to Accelerate R&D Efforts
March 24, 2020 -
GlobeNewswire
Menlo Therapeutics Appoints Andrew Saik as Chief Financial Officer
March 24, 2020 -
GlobeNewswire
Orchard Therapeutics Appoints Company Founder and Gene Therapy Pioneer Bobby Gaspar, M.D., Ph.D., as New Chief Executive Officer
March 18, 2020 -
GlobeNewswire
Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617
March 17, 2020 -
PR Newswire
Beijing Tide Pharmaceutical and Insilico Medicine enter into a strategic partnership agreement for cancer therapy
March 17, 2020 -
GlobeNewswire
Hua Medicine Announces 2019 Annual Results
March 16, 2020 -
GlobeNewswire
GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome
March 16, 2020 -
PR Newswire
Blueprint Medicines Announces Part 1 Results from PIONEER Trial Showing Broad Activity of Avapritinib Across Measures of Mast Cell Burden, Clinical Outcomes and Quality of Life in Indolent Systemic Mastocytosis
March 16, 2020 -
PR Newswire
Buoy Health Calms Coronavirus Fear, Serves Up Population Health Data to Help Control the Rising Epidemic in the United States
March 16, 2020 -
GlobeNewswire
Beam Therapeutics Announces Key R&D Appointments
March 16, 2020 -
GlobeNewswire
Acacia Pharma Announces Brief Extension of FDA Review Period for NDA for BYFAVO™, an Ultra-short Acting and Reversible Anesthetic for Procedural Sedation
March 12, 2020 -
GlobeNewswire
Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano
March 11, 2020 -
PR Newswire
TraceLink Achieves ISO 27017:2015 Security Certification
March 11, 2020 -
PR Newswire
TraceLink’s Continued Momentum Fuels Strong Company Growth and Investments in Q4 2019
March 10, 2020 -
Business Wire
Devoted Health recognized by Forbes as one of America’s Best Startup Employers in 2020
March 10, 2020 -
PR Newswire
Protenus Named One of Forbes’ Best Startup Employers of 2020
March 10, 2020 -
FierceBiotech
FierceMedTech names Insilico Medicine as one of its ‘Fierce 15’ companies of 2019
March 9, 2020 -
PR Newswire
PatientPing Launches Educational Website Dedicated to CMS’s Interoperability and Patient Access Rule
March 9, 2020 -
GlobeNewswire
SIGA Announces Collaboration with Turnstone Biologics
March 3, 2020 -
PR Newswire
TraceLink Launches Global Corporate Social Responsibility Program, Focusing on Community Service and Philanthropic Contributions to Healthcare and STEM Organizations
March 3, 2020 -
PR Newswire
Innovent Biologics Announces First Patient Dosed in the Pivotal Registrational Trial of Pemigatinib in Patients with Advanced Cholangiocarcinoma in China
March 3, 2020 -
Newswire
Artemis Health and Quantros Partner to Provide a Holistic View of Healthcare Provider Quality
March 2, 2020 -
GlobeNewswire
Acacia Pharma Announces Changes to its Officers and Board of Directors
March 2, 2020 -
FierceBiotech
Akrevia no more, Xilio Therapeutics bags $101M for I-O programs
March 2, 2020 -
FierceBiotech
Insilico Medicine taps GSK alum for a 6-month AI sprint aimed at brain cancer
February 27, 2020 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce FDA Acceptance and Priority Review Designation of Supplemental Biologics License Application for Crysvita® (burosumab) for Tumor-Induced Osteomalacia (TIO)
February 27, 2020 -
PR Newswire
Novaerus Donates Air Dis-infection Technology to Wuhan
February 27, 2020 -
GlobeNewswire
Acacia Pharma Announces US FDA Approval of BARHEMSYS® (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting (PONV)
February 27, 2020 -
Business Wire
Wellframe Announces Collaboration with Blue Cross and Blue Shield of Kansas City to Deliver Digital Health Management Solution to Members
February 24, 2020 -
Business Wire
Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
February 19, 2020 -
GlobeNewswire
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
February 18, 2020 -
PR Newswire
Breached Patient Records Tripled in 2019 as Malicious Actors Create New Problems for Patients
February 18, 2020 -
Business Wire
Nebula Genomics, Partnering with BGI, Sets Industry Standard by Offering 30x Whole-Genome Sequencing for $299
February 18, 2020 -
GlobeNewswire
Hua Medicine appoints Dr. Fuxing Tang, a former U.S. FDA Officer, as Chief Technology Officer
February 13, 2020 -
PR Newswire
Avidity Biosciences Appoints Joseph Baroldi as Chief Operating Officer
February 12, 2020 -
Business Wire
Atrius Health Engages Kyruus to Advance Novel Digital Patient Access Initiatives
February 12, 2020 -
GlobeNewswire
Orchard Therapeutics Announces Presentation of Clinical Data from Neurometabolic Franchise at 16th Annual WORLD Symposium
February 10, 2020 -
PR Newswire
Iora Health Closes $126 Million Series F Funding Round
February 10, 2020 -
Xconomy
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered
February 6, 2020 -
Fortune
Startup uses A.I. to identify molecules that could fight coronavirus
February 6, 2020 -
PR Newswire
Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor
February 6, 2020 -
GlobeNewswire
Menlo Therapeutics Announces Publication of Phase 2 Results for Serlopitant for the Treatment of Pruritus Associated with Psoriasis in the Journal of the American Academy of Dermatology
February 5, 2020 -
Endpoints News
F-Prime backs a niche AI software startup hunting lofty goals in $22M Series B
February 4, 2020 -
PR Newswire
Atrius Health And Firefly Health Announce Value-Based Care Affiliation
February 4, 2020 -
PR Newswire
PatientPing’s National Network of Next Generation ACO Providers Earns Over $150 Million in Savings for 2018
February 3, 2020 -
PR Newswire
2020 Best in KLAS Report Ranks Protenus No. 1 in Patient Privacy Monitoring
January 31, 2020 -
PR Web
Vitalware Achieves #1 in KLAS Revenue Cycle, Chargemaster Management Category for the Second Year in a Row
January 31, 2020 -
GlobeNewswire
Tempest Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPST-1495 and Welcomes New Investors
January 30, 2020 -
GlobeNewswire
Unum Therapeutics Provides Updates to its Phase 1 Trial of ACTR707 for HER2+ Solid Tumor Cancers
January 29, 2020
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.